Bacchetta Justine, Ranchère Dominique, Dijoud Frédérique, Droz Jean-Pierre
J Med Case Rep. 2009 Jun 5;3:7248. doi: 10.1186/1752-1947-3-7248.
Paraneoplastic glomerulopathies are rare manifestations of neoplastic disease to be distinguished from iatrogenic renal damage. Solid tumors are preferentially associated with membranous nephropathy, whereas Hodgkin's lymphomas are associated with minimal change disease.
We report a 63-year-old Caucasian male diagnosed with a mesothelioma of the tunica vaginalis testis who, secondary to this, also presented with a nephrotic syndrome due to minimal change disease. In the present case, the paraneoplastic etiology of the nephrotic syndrome can be discussed on four unusual elements: minimal change lesions were found; the glomerulopathy was very sensitive to corticosteroids; the nephrotic syndrome occurred 11 months after the diagnosis of the primary malignancy, but concomitantly with the recurrence; and the nephrotic syndrome did not decrease with tumor control and did not recur when the mesothelioma escaped treatment. No other etiologies could nevertheless explain this phenomenon.
Paraneoplastic nephrotic syndrome is often associated with membranous nephropathy in patients with solid tumors, especially in patients with lung and gastrointestinal tract neoplasia. The management of these patients is associated with a symptomatic treatment such as sodium and water restriction, diuretics and ACE inhibitors and a prophylaxis of specific complications of nephrotic syndrome including thromboembolism, infections and lipid abnormalities. Treatment of neoplasia must be undertaken rapidly, treatments must be regularly analyzed and drugs binding to albumin may be used with precaution.
副肿瘤性肾小球病是肿瘤性疾病的罕见表现,需与医源性肾损伤相鉴别。实体瘤优先与膜性肾病相关,而霍奇金淋巴瘤与微小病变肾病相关。
我们报告一名63岁的白种男性,诊断为睾丸鞘膜间皮瘤,继发于此,还因微小病变肾病出现了肾病综合征。在本病例中,肾病综合征的副肿瘤病因可基于四个不寻常的因素进行讨论:发现了微小病变;肾小球病对皮质类固醇非常敏感;肾病综合征在原发性恶性肿瘤诊断11个月后出现,但与复发同时发生;肾病综合征未随肿瘤控制而减轻,且在间皮瘤逃脱治疗时未复发。然而,没有其他病因可以解释这种现象。
实体瘤患者的副肿瘤性肾病综合征常与膜性肾病相关,尤其是在肺癌和胃肠道肿瘤患者中。这些患者的管理包括对症治疗,如限制钠和水摄入、使用利尿剂和血管紧张素转换酶抑制剂,以及预防肾病综合征的特定并发症,包括血栓栓塞、感染和脂质异常。必须迅速进行肿瘤治疗,定期分析治疗情况,并谨慎使用与白蛋白结合的药物。